Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before‐After Study

  title={Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before‐After Study},
  author={Paul Ellis Marik and Vikramjit S Khangoora and Racquel Rivera and Michael H. Hooper and John D. Catravas},

Figures and Tables from this paper

Vitamin C, Hydrocortisone, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Analysis of Real-World Application

A randomized controlled trial evaluating the effects of triple therapy is necessary prior to implementing vitamin C, hydrocortisone, and thiamine combination therapy as a standard of care in patients with septic shock.

Early Vitamin C, Hydrocortisone, and Thiamine Treatment for Septic Cardiomyopathy: A Propensity Score Analysis

It is suggested that early treatment using a vitamin C protocol might improve organ dysfunction and reduce mortality among patients with septic cardiomyopathy.

Combined hydrocortisone, ascorbic acid, and thiamine therapy for septic shock with complicated intraabdominal infection: before and after cohort study

Administration of HAT therapy may improve the recovery from organ dysfunction in patients with septic shock, according to a single-center, retrospective before-after clinical study comparing clinical outcomes.

Early administration of hydrocortisone, vitamin C, and thiamine in adult patients with septic shock: a randomized controlled clinical trial

Among adult patients with septic shock, early use of hydrocortisone, vitamin C, and thiamine combination therapy compared with placebo did not confer survival benefits.

Use of Hydrocortisone, Ascorbic Acid, and Thiamine in Adults with Septic Shock.

Administration of hydrocortisone, high-dose ascorbic acid, and thiamine (HAT therapy) among US adults with septic shock before and after publication of a single-center study is described and outcomes between patients who received, and did not receive, HAT therapy are compared.

Hydrocortisone, Vitamin C and thiamine for the treatment of sepsis and septic shock following cardiac surgery

Combination of vitamin C, thiamine and hydrocortisone reduces vasopressor requirement in adult cardiac surgical patients with septic shock and there was no difference in the Sepsis-Related Organ Failure Assessment (SOFA) score and mortality between the studied groups.

Hydrocortisone, ascorbic acid, and thiamine (HAT) for sepsis and septic shock: a meta-analysis with sequential trial analysis

The HAT combination improves the SOFA score in the first 72 h and reduces the duration of vasopressors in patients with sepsis, but the mortality benefit has not been observed.

Adding vitamin C to hydrocortisone lacks benefit in septic shock: a historical cohort study

In this small observational study of ICU patients with sepsis or septic shock, the addition of vitamin C to hydrocortisone therapy did significantly affect hospital mortality or other measures of mortality or organ dysfunction.



Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis: The HYPRESS Randomized Clinical Trial.

Among adults with severe sepsis not in septic shock, use of hydrocortisone compared with placebo did not reduce the risk of septicshock within 14 days, and these findings do not support the use ofHydroc Cortisone in these patients.

Procalcitonin kinetics within the first days of sepsis: relationship with the appropriateness of antibiotic therapy and the outcome

In a study in an ICU, appropriateness of the empirical antibiotic therapy and the overall survival were associated with a greater decline in procalcitonin (PCT) between D2 and D3, and PCT kinetics were found to be an independent predictor of survival.

Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study

PCT concentrations were higher in more severe forms of severe sepsis, but a substantial concentration decrease was more important for survival than absolute values.

Longitudinal changes in procalcitonin in a heterogeneous group of critically ill patients*

The presence of shock was significantly associated with elevations in procalcitonin in cohorts who were and were not infected, and dynamics were similar between surgical and medical cohorts.

De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock

De-escalation therapy for severe sepsis and septic shock is a safe strategy associated with a lower mortality and efforts to increase the frequency of this strategy are fully justified.

Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study

Administration of thiamine did not improve lactate levels or other outcomes in the overall group of patients with septic shock and elevated lactate and a statistically significant decrease in mortality over time was not found.

Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients

In septic patients, procalcitonin kinetics over the first 72 critical care hours provide prognostic information beyond that available from clinical risk scores that may assist physician decision-making regarding care intensification or early transfer from the ICU to the floor.

The effects of steroids during sepsis depend on dose and severity of illness: an updated meta-analysis.

Low-dose steroids appear to improve mortality rates in patients with septic shock who are at high risk of death; however, additional trials in this subpopulation are necessary to definitively determine the role of low- dose steroids during sepsis.